• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

About FDA

  • Print
  • Share
  • E-mail

Other Activities Performance Goals

<< Return to FY 2007 Budget Summary

 

Long Term Goal: Improve the efficiency and effectiveness of program management through focused performance budget and financial management strategies, aligned with FDA and HHS business strategies.
Measure FY Target Result
1. Increase the number of Commercial Activities that will be reviewed for competitive sourcing. (19003) (Efficiency) 2007 Review and Compete 154 FTE per "Green" Plan. 01/08
2006 Review and Compete 175 FTE 01/07
2005 (combined with FY 04) Conduct Clerical Study via competition of 350 FTE. (combined with FY04)
2004 (combined with FY 05) Conduct Clerical Study via competition of 350 FTE 350 FTE
2003

Review 145.7 FTE

167 FTE
2002

Review 72.7 FTE

 63 FTE

2. Maintain percentage of contract dollars allocated to performance based contracts (19006)

(Efficiency)

2007

NA

NA
2006

NA

NA
2005

50%

50%
2004

40%

50%

3. FDA's implementation of HHS's Unified Financial Management System (19017)

(Efficiency)

2007 FDA will finalize its decision on an activity-based costing application and make it operational for its user fee programs. 01/08
2006 FDA will pilot an activity-based costing application integrated with HHS UFMS project as part of Prescription Drug User Fee Act III. The UFMS and its FDA modules will be operational in FY05 allowing FDA's legacy system core financial system to be decommissioned during the first quarter of FY 2006

01/07

2005 FDA will implement a new core financial management system as part of the HHS UFMS project. The General Ledger and the Payroll interface will be implemented Oct. 1, 2004, and the remaining modules will be implemented April 1, 2005. Goal accomplished through various activities discussed under Performance text.
2004 FDA will hold a conference room pilot to prototype the design and configuration of UFMS. Begin development of FDA's unique interfaces and test global interfaces. Goal accomplished through various activities discussed under Performance text.
4. Reduce Administrative Staff. (efficiency goal -OMB approved) 2005 2623 2379
2004 2855 2766
2003
3086
Data Source: FDA Office of Management & Systems, 2001 FAIR Act Inventory. The agency will rely on the data from the Federal Procurement Data System (FPDS). The sources encompassed in the General Ledger & Federal Administrator, the Purchasing & Accounts Payable; and the Accounts Receivable. These sources are being prepared to transition to the Financial Business solutions systems.
Data Validation: FDA will ensure consistency in the tracking and reporting of the administrative management performance goals. In addition, FDA is taking steps to routinely monitor this data and take appropriate actions as needed. Data is from a variety of sources for these performance goals including the Annual Chief Financial Officer's Report, Civilian and Commission Corps personnel databases, monthly and annual full-time equivalent (FTE) reports and data-runs, the FDA FAIR Act Inventory and the FY 2001 FDA Workforce Restructuring Plan, monthly statements from bank card companies and the FDA Small Purchase System.
Cross Reference: These performance measures support HHS Strategic Goal 8. Measures 1,2 and 3 are Efficiency Goals.

 

Long Term Goal: Increase capability to efficiently and cost-effectively maintain an information technology (IT) environment to support FDA business goals.
Measure FY Target Result

5. Enhance the Agency Emergency preparedness and response capabilities to be better able to respond in the event of a terrorist attack. (19008)

(Output)

2007

Enhance functionality and continue deployment of the Emergency Operations Network Incident Management System throughout the Agency (HQ, Centers, Field offices).

Coordinate FDA's participation in exercises, including Topoff 4

Conduct and participate in exercises and workgroups related to emergency preparedness and response and counterterrorism.

Continue implementing the requirements of HSPD 12 by installing access control devices at FDA facilities including select agent laboratories.

01/08
2006

Enhance functionality and continue deployment of the Emergency Operations Network Incident Management System throughout the Agency (HQ, Centers, Field offices).

Revision of national and Agency emergency response and crisis management plans.

Conduct and participate in exercises and workgroups related to emergency preparedness and response and counterterrorism.

Begin implementation of the Federal Information Processing Standard 201 to remain in compliance with the requirements of HSPD-12.

01/07
2005 Develop the Agency's Emergency Operations Network Incident Management System (EON IMS). Goal accomplished. EON IMS version 2.2 was implemented in March 2005 and used during the April 2005 TOPOFF 3 Exercise.
2004 Develop Crisis Management Plan for CT. Develop the Agency's Emergency Operations Network. Goal accomplished through various activities discussed under Performance text.
Data Source: Office of Crisis Management/Office of Emergency Operations.
Data Validation: FDA will ensure consistency in the tracking and reporting of the administrative management performance goals. In addition, FDA is taking steps to routinely monitor this data and take appropriate actions as needed. Data are drawn from a variety of sources for these performance goals, including the Annual Chief Financial Officer's Report, Civilian and Commission Corps personnel databases, monthly and annual full-time equivalent (FTE) reports and data-runs, the FDA FAIR Act Inventory and the FY 2001 FDA Workforce Restructuring Plan, monthly statements from bank card companies and the FDA Small Purchase System.
Cross Reference: These performance measures support Strategic Goal 8.

 


1. Increase the number of Commercial FTE that will be reviewed for competitive sourcing. (19003)

  • Context of Goal: FDA annually searches its FAIR inventory for those commercial positions that have not undergone a competitive sourcing study. The objective of this search is to identify a sufficient number of positions that would fulfill FDA's requirement in meeting the OMB and DHHS established goal of reviewing all commercial positions by FY2013. The commercial positions are presented to FDA senior management in the form of logical business units to determine what will be reviewed that year. FDA is required under OMB's Green Plan to compete a minimum of 154 commercial FTEs each year until all commercial positions have been competed.The selected commercial business unit is announced for review and is then subjected to A-76 competitive sourcing competition either as one or more standard and/or streamline cost comparisons.
  • Performance: FDA successfully completed the FY04 and FY05 review of its 350 FTE Clerical Support Services function. The review determined that the FDA's Most Efficient Organization (MEO) would provide that service. This brings the total number of commercial FTE's reviewed to date to 580 FTE out of a baseline of 1,543 commercial FTE's. An additional 175 FTE will be reviewed in FY06 as FDA competes the operations and maintenance of its primary information technology infrastructure.


2. Maintain percentage of contract dollars allocated to performance-based contracts. (19006)

  • Context of Goal: FDA is aligning itself with the OMB goals of awarding 40 percent of eligible contract dollars to firms using performance based contracts by FY 05 and will strive to meet this target for FY 06 as well. This will lead to greater accountability of services provided by contractors, and increased efficiency. It should also be noted that not all contract dollars are eligible for this initiative.
  •  Performance: In FY 05, the FDA has awarded 50% of our eligible contract dollars to firms using performance-based contracts. In FY 04, FDA exceeded the target of 40% of eligible contract dollars awarded as performance-based contracts. FDA reviews each contract to determine if it is a candidate for performance based contracting. If so, the agency provides the contract's objectives and requests the contractor to provide the method(s) to meet the objective. Once the agency and contractor agree, FDA personnel regularly evaluate the contractor's performance. If necessary, the agency invokes a previously negotiated financial penalty against the contractor for failing to meet the objective(s). This allows the agency and contractor to assure high performance.


3. FDA's Implementation of HHS' Unified Financial Management System. (19017)

  • Context of Goal: The Department announced in FY 2001 that it intended to establish a unified financial management system to replace its operating division's individual financial management systems. The goal of the UFMS project is to reduce costs, mitigate security risks, and provide timely and accurate information across DHHS. FDA, CDC, NIH, and the Program Support Center (which covers the remaining components other than CMS and its contractors) began the design of the UFMS.
  • Performance: UFMS went live at FDA on schedule in April 2005. Part of the FDA Go-Live in April included the interfacing and implementation of iProcurement for purchasing requisition processing and funds control, and Prism for procurement processing. FDA was the first OPDIV to implement these HHS standard products. FDA successfully submitted its year end financial statements meeting the Departments delivery dates. Participated in the Departments top down consolidated audit which resulted in the Department once again receiving an Unqualified Audit opinion.

    FDA finalized the design and configuration of UFMS and begin the electronic interfaces for FDA's existing financial applications in FY 2004. FDA will acquire and implement a new core financial management system and related financial modules (accounts receivable, accounts payable, budget execution, and user fees) as part of the UFMS project in FY 2005. FDA will pilot an activity-based costing (ABC) application as part of the Prescription Drug User Fee Act III in FY 2006. FDA hopes to finalize the ABC financial module and make it operational for all of its user fee programs in FY 2007. FDA finalized its design and configuration of UFMS in February 2004. From that time until mid- December, progress was made to prepare for the interface testing. On December 17, UFMS teams at FDA performed integration testing on the UFMS. In FY 03 major components of data cleanup were completed. Travel Manager implementation has been complete throughout the Agency in preparation of UFMS.  


4. Reduce Administrative Staff.

  • Context of Goal: This FDA long term goal supports the Department's priorities including: strengthening management; consolidating management functions; completing competitive sourcing; and achieving administrative efficiencies. Additionally, it is part of FDA's implementation of the President's Management Agenda. Reaching this goal is a stretch because FDA already has low administrative overhead and has an extensive field operation that requires logistical support-provided by staff with positions classified as administrative - in order to effectively perform its public health protection function. In fact, FDA already has the second lowest percentage of administrative positions to mission critical positions in the Department in FY 03: FDA at 29.6 percent compared to CMS -46.4 percent, NIH -46 percent and CDC -42.2 percent.
  • Performance: FDA met this goal in both FY 2004 and FY 2005.


5. Enhance the Agency Emergency preparedness and response capabilities to be better able respond in the event of a terrorist attack. (19008)

  • Context of Goal: The Office of Crisis Management (OCM) includes the Office of Emergency Operations and the Office of Security Operations. OCM and its offices will continue to develop and implement goals that serve to improve and enhance the Agency's response capabilities to a terrorist attack. These activities continue to include the development of the Emergency Operations Network Incident Management System (EON IMS) which will provide seamless access to all FDA offices to enable them to respond quickly to the full range of FDA emergencies. The EON IMS will facilitate FDA's ability to integrate emergency related data and expertise in response to an incident of national significance as required by the National Response Plan and National Incident Management System (HSPD-5 and HSPD-8).

    The Network will be supported by an information technology infrastructure that will provide decision makers with quick access to emergency documents and information from all pertinent agency sources, as well as provide federal, state, local and international authorities with advisory information.

    Other initiatives that enhance the Agency's preparedness and response include:

    • Reviewing and revising the FDA Crisis Management Plan and Emergency Response Plans;
    • Conducting inter and intra-Agency terrorism and emergency response exercises;
    • Updating technology and equipment for the Office of Emergency Operations and the Office of Security Operations;
    • Continuing to install access control devices at FDA facilities including select agent laboratories in accordance with HSPD 12
    • Strengthening the coordination for inter and intra-Agency response involving laboratory testing;
    • Strengthening collaborations with science and public health, law enforcement, intelligence and international communities;
    • Continuing the development of the Agency's Emergency Operations Network Incident Management System;
  • Performance: In FY05, the Emergency Operations Network Incident Management System (EON IMS) designed, developed and implemented production system version 2.2. The system, fully certified and accredited in September, 2004, remains in use by the FDA Office of Crisis Management/Office of Emergency Operations. Shortly after version 2.2 was launched in March 2005, the EON IMS was used in the TOPOFF 3 Congressionally mandated exercise. It facilitated FDA's management of huge amounts of data related to two hypothetical terrorist events. The FDA Office of Crisis Management/Office of Emergency Operations uses the EON IMS to assist in the management and coordination of the Agency's response to incidents regarding FDA regulated commodities, including outbreaks, natural disasters, e.g., hurricanes and actual or potential product defects that pose a risk to human or animal health. OCM used the mapping capabilities of EON IMS to generate geo-coded maps, which proved instrumental in the Agency's development of inspection plans and assignments related to Hurricanes Katrina and Rita.

    OCM issued the final version of FDA's Crisis Management Plan (Version 2.3) in March 2005. The plan provides the Agency with a structured methodology that enables FDA to respond to crisis situations that are beyond the capabilities of existing FDA emergency response resources. It incorporates elements describing the process by which the Agency identifies a crisis as well as the role of crisis communications in FDA's response to a crisis.

    In FY05, the Emergency Operations Center updated its technological infrastructure furthering the Agency's emergency preparedness capabilities in the event of a large-scale disaster or attack. The Office of Crisis Management continued to engage in partnerships and cooperative efforts to further the development of the HHS Strategic Exercise Plan and a Food and Agriculture Annex to the National Response Plan and to work with federal, state, local and international groups to develop best practices for emergency preparedness and response and develop exercises.

    OCM participated fully in two major emergency preparedness and response exercises-TOPOFF 3 and the HHS Public Affairs OPDIVs Exercise. As follow-up to TOPOFF 3 exercise, participated in three-day T3 Large Scale Game Exercise.

 

<< Return to FY 2007 Budget Summary